Form 4 for NBIX NEUROCRINE BIOSCIENCES INC

Accepted 2024-02-08 00:00:00 ET · period of report 2024-02-06 · accession 0000914475-24-000050 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-02-08	2024-02-06+	NBIX	Cooke Julie	CHRO	S - Sale	$138.61	-2,544	17.3K	-13%	-$352.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-06	S	D	640	$142.17	17,838	D	—	—	(F2) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $141.05 to $143.13. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
2	Common	Common Stock	2024-02-06	S	D	575	$141.96	17,263	D	—	—
3	Common	Common Stock	2024-02-08	S	D	700	$134.23	17,892	D	—	—	(F5) Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $132.64 to $136.28 The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
4	Common	Common Stock	2024-02-08	S	D	629	$136.78	17,263	D	—	—	(F6) 15,825 of the reported shares are held by the Cooke Family Trust of 2004 U/A 12/28/2004, of which the Reporting Person has voting and investment power.